Emilia Barańska-Bała, Paulina Małachowska, Agnieszka Koper, Sławomir Wileński, Krzysztof Koper
{"title":"原发性根治性治疗对女性晚期乳腺癌患者全身核波西尼治疗的有效性和安全性的影响","authors":"Emilia Barańska-Bała, Paulina Małachowska, Agnieszka Koper, Sławomir Wileński, Krzysztof Koper","doi":"10.5603/mrj.97119","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18485,"journal":{"name":"Medical Research Journal","volume":"64 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The impact of primary radical treatment on the effectiveness and safety of systemic treatment with ribociclib in female patients with advanced breast cancer\",\"authors\":\"Emilia Barańska-Bała, Paulina Małachowska, Agnieszka Koper, Sławomir Wileński, Krzysztof Koper\",\"doi\":\"10.5603/mrj.97119\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18485,\"journal\":{\"name\":\"Medical Research Journal\",\"volume\":\"64 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Research Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/mrj.97119\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Research Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/mrj.97119","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The impact of primary radical treatment on the effectiveness and safety of systemic treatment with ribociclib in female patients with advanced breast cancer